1995
DOI: 10.1097/00001721-199505000-00006
|View full text |Cite
|
Sign up to set email alerts
|

Carbazochrome sodium sulphonate (AC-17) decreases the accumulation of tissue-type plasminogen activator in culture medium of human umbilical vein endothelial cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2003
2003
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…CSS reduces permeability and enhances contractility of capillaries [11]. Only 2 previous studies have evaluated the hemostatic effect of CSS in TKA, with both showing CSS to have a beneficial effect on hemostatic, with no increased risk of asymptomatic DVT [12,35].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…CSS reduces permeability and enhances contractility of capillaries [11]. Only 2 previous studies have evaluated the hemostatic effect of CSS in TKA, with both showing CSS to have a beneficial effect on hemostatic, with no increased risk of asymptomatic DVT [12,35].…”
Section: Discussionmentioning
confidence: 99%
“…Carbazochrome sodium sulfonate (CSS) is a capillary stabilizer that reduces capillary permeability and enhances contraction of broken capillary ends [11,12]. It is used to treat bleeding diseases of the urinary system, upper digestion, respiratory tract, and in obstetrics and gynecology [13,14].…”
mentioning
confidence: 99%
“…Comparison of usage of platelet infusion or hemostat agents. We also investigated the usage of platelet infusion or hemostat agents (tranexamic acid, 24 carbazochrome sodium sulfonate hydrate, 25 and viamin K 26 ) for the prevention of hemorrhage. Usage rate of hemostat agent in non-dialyzed patients was significantly higher than that in dialyzed ESRD patients (63.2% vs 55.6%, P = 0.006) ( Table 5).…”
Section: Comparisonmentioning
confidence: 99%
“…Carbazochrome sodium sulfonate (CSS) can be used to treat bleeding due to its ability to increase capillary permeability and enhance the contraction of broken ends of capillaries. 12 , 13 Although the mechanism of action is still unclear, recent studies have shown that it could reverse thrombin-, trypsin-, and bradykinin-induced increase of endothelial cell permeability by reducing the formation of intracellular actin stress fibres and restoring tight cellular connectivity. 14 , 15 Furthermore, CSS is also used in urology, otolaryngology, etc., and studies have shown that CSS can improve symptoms of nose bleeding as well as pain and post-urination symptoms in patients with refractory chronic prostatitis.…”
Section: Introductionmentioning
confidence: 99%